Skip to main content
Caplight Logo









Sea4Us

Sea4Us

Private
SagresHealthcare & Life Scienceshttps://sea4us.pt/en/

Last Round

Crowdfunding

Aug 13, 2025

Total Funding Raised

$9.54M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Sea4Us is a biotechnology company that discovers and develops new pharmaceutical drugs from marine organisms to treat conditions like chronic pain, epilepsy, and diabetes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverymarine biotechnologychronic pain managementnon-opioid analgesicion channel modulationpharmaceutical licensingmarine pharmacologydrug developmentlife science consultancyblue biotechpain therapeuticspreclinical researchmarine exploration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sea4Us Comparables

Compare Sea4Us with similar companies based on industry and business-model similarity.

Sea4Us comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Latigo Biotherapeutics
82%
Sirenas Marine Discovery
78%
Eli Lilly and Company
76%

Sea4Us Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingAug 13, 2025
DebtFeb 18, 2025
AcceleratorNov 29, 2023
DebtJul 1, 2023
Early FundingJul 22, 2021
Grant
Mar 23, 2018

Key People

Founding team and executive leadership

Nuno Leitao

Co-Founder And CFO

Founding Team

Pedro Lima

CEO, CSO And Co-founder, Co-founder Promoter

Founding Team

Tânia Catarina Ferreira

COO, Business And Innovation Manager, PM4Public Funds

Executive Team

Sea4Us Investors

Notable investors and investment history

Sea4Us investors
InvestorRounds
European Innovation Council FundDebt, Accelerator
European CommissionGrant
EIC FundAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 73% MoM.

  • Apr 17, 2026

    Monthly visitors increased 82% MoM.

Sea4Us Filings

Explore SEC and related filing metadata, where available.

Sea4Us filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sea4Us's valuation, stock price, and market status.

Is Sea4Us a public or private company?

Sea4Us is a private company.

What is the current stock price of Sea4Us?

Sea4Us is a private company with no public stock price. No recent secondary market data is available.

How much is Sea4Us worth (valuation)?

Valuation information for Sea4Us is not publicly available.

Can I buy Sea4Us stock?

Sea4Us shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sea4Us's last funding round?

Sea4Us's most recent funding round was Debt on August 1, 2025.

Who are the main investors in Sea4Us?

Key investors in Sea4Us include EIC Fund.

Will Sea4Us IPO soon?

No public IPO plans have been announced for Sea4Us.

How can I track Sea4Us secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sea4Us's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSagres
Employee Range23
Year Founded2013
Last FundingAug 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?